Top Clinical Trials companies in Poland by Net Cash Used For Investing Activities
Poland
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 5.05 M
|
Dec. 31, 2023 | USD 12.20 | -4.46% |
|
Poland |
|
| 2 |
USD -1.71 M
|
Dec. 31, 2023 | USD 1.79 | -1.96% |
|
Poland |
|
| 3 |
USD -8.01 M
|
Dec. 31, 2023 | USD 9.53 | 2.20% |
|
Poland |
|
| 4 |
USD -11.29 M
|
Dec. 31, 2023 | USD 2.23 | -2.90% |
|
Poland |
|
| 5 |
USD -16.54 M
|
Dec. 31, 2023 | USD 10.51 | -3.97% |
|
Poland |
|
| 6 |
USD -50.88 M
|
Dec. 31, 2023 | USD 6.53 | 2.36% |
|
Poland |
Frequently Asked Questions
-
Which Clinical Trials company in Poland has the highest Net Cash Used For Investing Activities ?
The Clinical Trials company in Poland with the highest Net Cash Used For Investing Activities is Captor Therapeutics Spolka Akcyjna (Warsaw Stock Exchange: CTX.WA) at USD 5.05 M.
-
Which Clinical Trials company in Poland has the lowest Net Cash Used For Investing Activities ?
The Clinical Trials company in Poland with the lowest Net Cash Used For Investing Activities is Ryvu Therapeutics S.A. (Warsaw Stock Exchange: RVU.WA) at USD -50.88 M.
-
What are the top 10 Clinical Trials companies in Poland by Net Cash Used For Investing Activities ?
The top 10 Clinical Trials companies in Poland by Net Cash Used For Investing Activities are Captor Therapeutics Spolka Akcyjna, Medinice S.A., Poltreg S.A., Molecure S.A., Selvita S.A. and Ryvu Therapeutics S.A..
-
What are the bottom 10 Clinical Trials companies in Poland by Net Cash Used For Investing Activities ?
The bottom 10 Clinical Trials companies in Poland by Net Cash Used For Investing Activities are Ryvu Therapeutics S.A., Selvita S.A., Molecure S.A., Poltreg S.A., Medinice S.A. and Captor Therapeutics Spolka Akcyjna.
